Skip to main content
. 2015 Mar 5;16(8):853–862. doi: 10.1093/ehjci/jeu314

Figure 1.

Figure 1

(A) Event-free survival (Kaplan–Meier curve) from major adverse events (all-cause mortality, non-fatal MI, and coronary revascularization) with follow-up extending to 5 years in patients with RCD and LCD stratified for the presence of obstructive CAD (>50%) on CCTA. Patients with a balanced coronary artery system were excluded from the analysis, because of the low number of patients in this group. (B) Event-free survival (Kaplan–Meier curve) from major adverse events (all-cause mortality, non-fatal MI, and coronary revascularization) in patients with RCD and LCD stratified for normal coronary arteries. Patients with a balanced coronary artery system were excluded from the analysis, because of the low number of patients in this group.